MarketPeel
EVP R&D, Chief Medical Officer
Mon, Mar 2, 2026
Mar 2
received an award in ALKS
38,568 shares @ $0.00
New position
ALKSAlkermes plc.
Health CarePharmaceuticals
1D+1.12%
1W-1.97%
1M-7.60%
3M+30.84%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback